Results 181 to 190 of about 415,817 (366)

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Nutritional Support in Pancreatic Diseases. [PDF]

Nutrients, 2022
Cañamares-Orbís P, García-Rayado G, Alfaro-Almajano E.   +2 more
europepmc   +1 more source

A Novel 3D High‐Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer

Advanced Healthcare Materials, EarlyView.
Ovarian cancer's high recurrence and therapy resistance demand new strategies. A high‐throughput drug screening pipeline using 3D spheroids, which showed poor concordance with 2D models, identified rapamycin as a promising candidate. In combination with cisplatin, rapamycin demonstrated significant in vitro and in vivo efficacy, highlighting the ...
Nazanin Karimnia, Amy L. Wilson, Brittany R. Doran, Jennie Do, Amelia Matthews, Gwo Y. Ho, Magdalena Plebanski, Thomas W. Jobling, Andrew N. Stephens, Maree Bilandzic   +9 more
wiley   +1 more source

The insulin response to glucose in patients with pancreatic disease

, 1969
M. T. McKiddie, G C McBain, K. D. Buchanan, G. H. Bell   +3 more
openalex   +1 more source

Changes in Pancreatic Senescence Mediate Pancreatic Diseases. [PDF]

Int J Mol Sci, 2023
Li K, Bian J, Xiao Y, Wang D, Han L, He C, Gong L, Wang M.   +7 more
europepmc   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma

Frontiers in Medicine, 2023
Shui Liu, Shui Liu, Qiao Li, Qiao Li, Yongzhi Li, Yongzhi Li, Jiyao Sheng, Jiyao Sheng   +7 more
doaj   +1 more source

Portal Hypertension Secondary to Pancreatic Disease *

, 1960
William V. McDicrmott
openalex   +2 more sources

Amylase assay and diagnosis of pancreatic disease. [PDF]

, 1985
John Lott, E C Ellison
openalex   +1 more source

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study. [PDF]

Front Immunol, 2023
Yuan S, Miao Y, Ruan X, Chen J, Li X, Larsson SC.   +5 more
europepmc   +1 more source